SEC fines Allergan $15 million for slow disclosure of merger discussions
January 18, 2017 at 09:19 AM EST
Allergan PLC will pay $15 million in fines and admit to disclosure violations during a hostile takeover bid from Valeant Pharmaceuticals International Inc., the Securities and Exchange Commission said Tuesday.
